Support for HI3 and the four funded research programs through the CBRF and BRIF is part of a larger investment in Canada’s Biomanufacturing and Life Sciences Strategy
The Institutional Strategic Initiative brings together multi-disciplinary research talent and innovators to tackle unmet needs in drug discovery, diagnostics, and disease biology